Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) Net Margin: 2010-2021

Historic Net Margin for Neurocrine Biosciences (NBIX) over the last 9 years, with Sep 2021 value amounting to 7.60%.

  • Neurocrine Biosciences' Net Margin rose 2988.00% to 7.60% in Q3 2021 from the same period last year, while for Sep 2021 it was 3.67%, marking a year-over-year decrease of 529.00%. This contributed to the annual value of 4.70% for FY2019, which is 2.00% up from last year.
  • Per Neurocrine Biosciences' latest filing, its Net Margin stood at 7.60% for Q3 2021, which was down 48.08% from 14.64% recorded in Q2 2021.
  • In the past 5 years, Neurocrine Biosciences' Net Margin ranged from a high of 33.45% in Q3 2018 and a low of -960.76% during Q2 2017.
  • For the 3-year period, Neurocrine Biosciences' Net Margin averaged around 4.80%, with its median value being 14.29% (2019).
  • In the last 5 years, Neurocrine Biosciences' Net Margin spiked by 95,466bps in 2018 and then crashed by 4,651bps in 2020.
  • Neurocrine Biosciences' Net Margin (Quarterly) stood at 7.29% in 2017, then surged by 701bps to 14.30% in 2018, then crashed by 37bps to 13.93% in 2019, then tumbled by 4,651bps to -22.28% in 2020, then surged by 2,988bps to 7.60% in 2021.
  • Its last three reported values are 7.60% in Q3 2021, 14.64% for Q2 2021, and 13.57% during Q1 2021.